Compared with healthy controls and systemic sclerosis (SSc) patients, SLE patients presented a higher expression of endothelial cell MP (EMP), suggesting that EMP has potential as a biomarker for SLE vascular lesions (76). Here, MAEA is linked to systemic lupus erythematosus.